69059-78-5

Upstream product

• 94-02-0 ethyl 3-oxo-3-phenylpropionate 
• 106-49-0 p-toluidine 

Downstream Products

• 69059-85-4 5-phenyl-2-p-tolyl-2H-[1,2,3]triazole-4-carboxylic acid amide 
• 934290-44-5 C₁₆H₁₀Br₂N₄ 
• 934290-45-6 C₁₆H₁₀N₄O₂ 
• 934290-43-4 C₁₆H₉Br₃N₄ 
• 69059-86-5 5-phenyl-2-p-tolyl-2H-[1,2,3]triazole-4-carbonitrile 

Relevant academic research and scientific papers

NITROGENATED HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention relates to novel compounds having a xanthine oxidase inhibitory effect and an uricosuric effect and pharmaceutical compositions comprising the same as an active ingredient. That is, the present invention relates nitrogen-containing heterocyclic compounds represented by the following general formula (I): wherein Y1 represents N or C(R4) ; Y2 represents N or C(R5) ; R4 and R5 independently represent an alkyl group, a hydrogen atom etc. ; one of R1 and R2 represents an optionally substituted aryl group, an alkoxygroup or an optionally substituted heterocyclic group; the other of R1 and R2 represents a haloalkyl group, a cyanogroup, ahalogenatometc.; and R3 represents a 5-tetrazolyl group or a carboxy group, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising the same as an active ingredient.

Novel stilbene compounds

Stilbene compounds of the formula STR1 in which the rings A, B and C can carry non-chromophoric substituents, R1 is hydrogen, alkyl which is unsubstituted or substituted by non-chromophoric substituents, or aryl which is unsubstituted or substituted by non-chromophoric substituents, and R2 is a carboxyl group or a functional derivative thereof, a cyano group, a sulphonic acid ester group, a sulphonamide group or a sulphonyl group, and the use thereof as fluorescent brightening agents for high-molecular organic material.